Notably, we also report amplification of this region in a small subset of human acute myeloid leukemia (AML) that is associated with TP53 alterations and, moreover, amplification of this region in mouse and human tumors leads to the overexpression of several candidate or known cancer genes including Mll/Kmt2a. Here, TP53 is linked to cancer.